Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Coeptis Therapeutics Holdings (COEP) Gross Margin (2025)

Historic Gross Margin for Coeptis Therapeutics Holdings (COEP) over the last 1 years, with Q3 2025 value amounting to 80.98%.

  • Coeptis Therapeutics Holdings' Gross Margin changed N/A to 80.98% in Q3 2025 from the same period last year, while for Sep 2025 it was 72.96%, marking a year-over-year change of. This contributed to the annual value of 100.0% for FY2021, which is N/A changed from last year.
  • Coeptis Therapeutics Holdings' Gross Margin amounted to 80.98% in Q3 2025.
  • In the past 5 years, Coeptis Therapeutics Holdings' Gross Margin ranged from a high of 80.98% in Q3 2025 and a low of 28.18% during Q1 2025